Skip to main content
Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

48 views
Download
Pharmaceutical

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Advanced pharmaceutical formulation for targeted therapeutic intervention.

Dosage

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Strength

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Pack Size

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Form

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Source

European Medicines Agency

View Source

Safety Profile

Contraindications

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Side Effects

Pregabalin Pfizer-H-C-PSUSA-00002511-202001: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Related Clinical Articles

Scan this QR code to access this page quickly on your mobile device.

QR Code